Cellebrite DI Ltd.

NASDAQ:CLBT

18.49 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -81.1120.80571.3965.781-1.876
Depreciation & Amortization 10.0119.1947.0915.8794.079
Deferred Income Tax 5.125-2.392-1.638-2.818-1.667
Stock Based Compensation 18.99813.7086.487.27112.759
Change In Working Capital 38.519-2.81920.58649.7712.707
Accounts Receivables 2.271-12.885-1.958-19.731-12.22
Inventory 0.243-3.68-1.798-0.6930.794
Accounts Payables 4.425-5.4714.155-1.4330.974
Other Working Capital 31.5819.21720.18771.62813.159
Other Non Cash Items 110.505-117.919-67.8630.6260.131
Operating Cash Flow 102.05820.57736.05266.5116.133
Investing Activities:
Investments In Property Plant And Equipment -7.918-9.085-8.111-6.181-6.209
Acquisitions Net 0106.611-20-15.0460
Purchases Of Investments -55.317-165.364-21-138.50
Sales Maturities Of Investments 56.33683.21894.337153.2780
Other Investing Activites -15.641-106.61170.33714.778-40.513
Investing Cash Flow -22.54-91.23145.226-6.449-46.722
Financing Activities:
Debt Repayment -4.36200-1.4920
Common Stock Issued 21.76513.972.3051.4920
Common Stock Repurchased 000-0.085-0.808
Dividends Paid 00-100-10-25
Other Financing Activities 4.36213.9729.2981.492101.346
Financing Cash Flow 21.76513.97-68.397-8.59375.538
Other Information:
Effect Of Forex Changes On Cash 0.589-1.644-0.7540.695-0.067
Net Change In Cash 101.872-58.32812.12752.16344.882
Cash At End Of Period 189.51787.645145.973133.84681.683